Full formMedical & Health
PXHstands forPleomorphic Xanthoastrocytoma
Full Form of PXH
What is PXH?
Pleomorphic xanthoastrocytoma (PXA) is a rare, low-grade brain tumor that primarily affects children and young adults. Classified as a Grade II tumor by the World Health Organization, it arises from astrocytes—a type of glial cell—and is most commonly found in the temporal lobe of the brain. In India, PXA cases are diagnosed at specialized neuro-oncology centers, such as the All India Institute of Medical Sciences (AIIMS) and Tata Memorial Hospital. Symptoms often include seizures, headaches, and focal neurological deficits, reflecting the tumor's location. Diagnosis relies on MRI and histopathological analysis, where characteristic pleomorphic cells and xanthomatous (lipid-laden) features are observed. Surgical resection is the primary treatment, with favorable prognosis when complete removal is achieved. Radiotherapy or chemotherapy may be considered for recurrent or atypical cases. PXA is occasionally referenced in Indian medical entrance exams (e.g., NEET PG) and neurology board examinations, highlighting its clinical rarity and diagnostic hallmarks. Awareness among Indian neurologists and neurosurgeons is crucial for timely intervention and management.
PXH का फुल फॉर्म
प्लीओमॉर्फिक ज़ैंथोएस्ट्रोसाइटोमा
Example
The 22-year-old patient presented with new-onset seizures, and subsequent MRI revealed a enhancing lesion in the left temporal lobe, later confirmed as a pleomorphic xanthoastrocytoma (PXH) on biopsy.
PXH — frequently asked questions
What is the full form of PXH?
PXH stands for Pleomorphic Xanthoastrocytoma, a rare brain tumor classified as a grade II astrocytoma by the World Health Organization.
Is pleomorphic xanthoastrocytoma malignant?
Pleomorphic xanthoastrocytoma is typically a low-grade (benign) tumor, but it has potential to recur or transform into a higher-grade malignancy in some cases.
What are the common symptoms of PXH in Indian patients?
Common symptoms include chronic headaches, seizures, and focal neurological deficits such as weakness or speech difficulties, often due to the tumor's location in the temporal lobe.